You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Muscarinic Receptor Antagonist

Showing 1 - 25 of 9,958
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

A Retrospective rEal-life daTa Study to Assess exaceRbations and

Completed
  • COPD
  • COPD Exacerbation
    • Thessaloniki, Greece
      Papanikolaou Hospital of Thessaloniki
    Sep 7, 2022

    Muscarinic Receptor Occupancy Trial in New Haven (Scopolamine, [11C]EMO ([11C]LSN3172176))

    Not yet recruiting
    • Muscarinic Receptor Occupancy
    • New Haven, Connecticut
      Yale University
    Aug 31, 2023

    Multiple Sclerosis Trial in London (PIPE-307)

    Completed
    • Multiple Sclerosis
    • London, United Kingdom
      Hammersmith Medicines Research
    Oct 4, 2022

    LARS - Low Anterior Resection Syndrome Trial in Seoul (Ramosetron)

    Not yet recruiting
    • LARS - Low Anterior Resection Syndrome
    • Seoul, Jongro-gu, Korea, Republic of
      Seoul National University Hospital
    Dec 13, 2022

    Safety Issues, Pain, Pancreas Fibrosis Trial in Washington (Proglumide, Placebo)

    Recruiting
    • Safety Issues
    • +2 more
    • Washington, District of Columbia
      Georgetown University
    Dec 1, 2022

    Monitoring Drug Efficacy in Patients With Alzheimer's Disease

    Recruiting
    • Alzheimer Disease
    • AChE inhibitor monotherapy
    • AChE inhibitor and NMDA receptor antagonist combination therapy
    • Manila, Metro Manila, Philippines
      Philippine General Hospital
    Mar 24, 2023

    Schizophrenia, Schizoaffective Disorder, Healthy Trial in New Haven (11C-EMO - A Novel PET Radiotracer for Muscarinic M1

    Recruiting
    • Schizophrenia
    • +2 more
    • 11C-EMO - A Novel PET Radiotracer for Muscarinic M1 Receptor
    • New Haven, Connecticut
      Connecticut Mental Health Center
    Sep 16, 2022

    Prostate Cancer, Prostate Adenocarcinoma Trial (drug, other, procedure)

    Not yet recruiting
    • Prostate Cancer
    • Prostate Adenocarcinoma
    • (no location specified)
    Feb 2, 2023

    Epidermolysis Bullosa Trial in Redwood City (Serlopitant Tablet, Placebo Oral Tablet)

    Completed
    Has Results
    • Epidermolysis Bullosa
    • Serlopitant Tablet
    • Placebo Oral Tablet
    • Redwood City, California
      Stanford University
    Nov 30, 2022

    Prostatic Tumors Trial in Beijing, NanJing, ShangHai (Apalutamide)

    Active, not recruiting
    • Prostatic Neoplasms
    • Beijing, China
    • +3 more
    Jan 17, 2023

    Rectal Cancer Trial in Frankfurt (drug, radiation, procedure)

    Recruiting
    • Rectal Cancer
    • Kineret 100 MG in 0.67 ML Prefilled Syringe
    • +3 more
    • Frankfurt, Germany
      University Hospital Goethe University Frankfurt
    Aug 23, 2022

    Sleep Initiation and Maintenance Disorders, Stress Disorders, Posttraumatic Trial in San Francisco, Salisbury (Suvorexant,

    Recruiting
    • Sleep Initiation and Maintenance Disorders
    • Stress Disorders, Posttraumatic
    • San Francisco, California
    • +1 more
    Nov 10, 2022

    Healthy Volunteers Trial in Stockholm (AZD2115, SPIRIVA, [11C]AZ13754366)

    Completed
    • Healthy Volunteers
    • Stockholm, Sweden
      Research Site
    Aug 27, 2021

    Acute Respiratory Distress Syndrome Trial in Montréal (Placebo, Ondansetron Injection)

    Not yet recruiting
    • Acute Respiratory Distress Syndrome
    • Placebo
    • Ondansetron Injection
    • Montréal, Quebec, Canada
      Hôpital Sacré-Coeur de Montréal
    Aug 22, 2022

    Primary Aldosteronism, Hypertension Trial (Finerenone, Spironolactone)

    Not yet recruiting
    • Primary Aldosteronism
    • Hypertension
    • (no location specified)
    Apr 3, 2023

    PTSD Trial in San Francisco (CORT108297, Placebo)

    Not yet recruiting
    • PTSD
    • San Francisco, California
      San Francisco VA Medical Center, San Francisco, CA
    Jul 26, 2022

    Rotator Cuff Tendinitis, Chronic Pain Trial in Kristiansund (Ketalar, NaCl 9%)

    Recruiting
    • Rotator Cuff Tendinitis
    • Chronic Pain
    • Kristiansund, Norway
      Department of Orthopedic Surgery, Kristiansund Hospital
    Mar 15, 2022

    COPD Trial in Llanelli (Any LABA/LAMA)

    Completed
    • Chronic Obstructive Pulmonary Disease
    • Any LABA/LAMA
    • Llanelli, Carmarthenshire, United Kingdom
      Prince Philip Hospital
    Aug 2, 2022

    Renal Cell Carcinoma Trial in Houston (Ipilimumab, Nivolumab, Ciforadenant)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 11, 2022

    COVID-19, SARS-CoV2 Infection Trial in India (Candesartan Cilexetil, Repagermanium, Candesartan Placebo)

    Recruiting
    • COVID-19
    • SARS-CoV2 Infection
    • Candesartan Cilexetil
    • +3 more
    • Guntur, India
    • +4 more
    Mar 13, 2022

    Depressive Disorder, Major, Anxiety Disorder Trial (Nociceptin Receptor Antagonist, Aversive stimuli)

    Not yet recruiting
    • Depressive Disorder, Major
    • Anxiety Disorder
    • Nociceptin Receptor Antagonist
    • Aversive stimuli
    • (no location specified)
    Nov 3, 2022

    Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR

    Not yet recruiting
    • Pericarditis
    • IL1RA Antibody Assay
    • suPAR Testing
    • Homburg, Germany
    • +8 more
    Jun 22, 2023

    Cardiovascular Diseases, Vascular Dilation Trial in Worcester (Ifetroban Sodium, Placebo)

    Recruiting
    • Cardiovascular Diseases
    • Vascular Dilation
    • Ifetroban Sodium
    • Placebo
    • Worcester, Massachusetts
      University of Massachusetts Medical School
    Feb 16, 2022

    Steatohepatitis, Nonalcoholic Trial in Shibin Al Kawm (Control group, Montelukast group)

    Completed
    • Steatohepatitis, Nonalcoholic
    • Control group
    • Montelukast group
    • Shibīn Al Kawm, Menoufia, Egypt
      Faculty of Medicine
    Mar 15, 2022

    Exercise, Histamine Trial in Ghent (Placebo: Placebo + exercise training., H1 blockade: H1 receptor antagonist + exercise

    Active, not recruiting
    • Exercise
    • Histamine
    • Placebo: Placebo + exercise training.
    • +2 more
    • Ghent, Oost-Vlaanderen, Belgium
      Department of movement and sports sciences, Ghent University, Be
    Nov 8, 2022